IMPAVIDO 50mg capsules medication leaflet

P01CX04 miltefosine • Antiparasitic products, insecticides and repellents | Agents against leishmaniasis and trypanosomiasis | Other agents against leishmaniasis and trypanosomiasis

Miltefosine is an antiprotozoal agent used for the treatment of visceral and cutaneous leishmaniasis. It works by disrupting the cell membranes of the parasite, leading to its death.

The medication is taken orally, usually once or twice daily, with the duration of treatment varying based on the type and severity of the infection. Common side effects include nausea, vomiting, diarrhea, and abdominal pain.

Miltefosine is contraindicated in pregnant and breastfeeding women, as well as in patients with hypersensitivity to the active substance. Its use also requires careful monitoring to prevent renal and hepatic toxicity.

This medication is an important option for the treatment of leishmaniasis, helping to reduce mortality and alleviate symptoms.

General data about IMPAVIDO 50mg

Substance: miltefosine

Date of last drug list: 01-06-2025

Commercial code: W69190001

Concentration: 50mg

Pharmaceutical form: capsules

Quantity: 56

Product type: generic

Price: 14513.54 RON

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

Manufacturer: PAESEL + LOREI GMBH & CO. KG - GERMANIA

Holder: CN UNIFARM S.A. - ROMANIA

Number: 748/2022/01

Shelf life: 5 years

Pharmaceutical forms available for miltefosine

Concentrations available for miltefosine

50mg, 60mg/ml